Learn More
Medchemexpress LLC AKB-6899 | 1007377-55-0 | 99.9% | 290.25 | 25 MG

Supplier: Medchemexpress LLC 25MGHY113649
AKB-6899, a prolyl hydroxylase domain 3 (PHD3) inhibitor, is a selective HIF-2α stabilizer. It also increases soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages, and has antitumor and antiangiogenic effects.
- PHD3 inhibitor
- Selective HIF-2α stabilizer
- Increases soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages
- Has antitumor effects
- Has antiangiogenic effects
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.